Click to discover upcoming conferences and workshops
Read about projects and research interests of our collaborators…
Watch recorded presentations and talks from our network events UK…
Focus workshops addressing the challenges of stratified medicine …
Courses and seminars on genetics, genomics and stratified medicine…
Funding opportunities for research into stratified medicine
Articles from the field of stratified medicine and pharmacogenetics... Defining…
The high profile committee guiding the UK PGx Network…
The network is made up of experts from academia, healthcare sector, industry, regulatory bodies and patient groups
and aims to develop collaborations between these different sectors to advance the adoption of stratified medicine into the clinic.
If you need to find a research partner, simply click to download the collaboration form, provide information on your current project(s)
and we will advertise your request to help put you in touch with the relevant individual or institution.
Upcoming Events & Funding Deadlines
|19 Jan 2017|
Cross-cutting KETs for diagnostics at the point-of-care
|23 Jan 2017|
Precision Medicine World Conference 2017: Silicon Valley, USA
|24 Jan 2017|
"NIHR Research Programmes: Obtaining NIHR Funding and the Application Process” event
|26 Jan 2017|
NIHR Global Health Research
|27 Jan 2017|
Electronic Prescribing In Hospitals: Moving Forward
|30 Jan 2017|
|31 Jan 2017|
Festival of Genomics : London
|02 Feb 2017|
OBN BioLearn™: How the Drugs Discovery Industry Works
|02 Feb 2017|
Response mode: Neurosciences & Mental Health Board
|10 Feb 2017|
Non-Medical Prescribing for Pain
What is Pharmacogenetics?
What is Stratified Medicine?
Stratified medicine (also described as personalised, precision, or P4 Predictive, Preventive, Personalized and Participatory medicine) uses technical advances in genetic sequencing techniques, and bespoke diagnostic tests, to prescribe the drug that is most likely to have a positive therapeutic effect, at the optimum dose and in the right combination with other medication, to patients at the start of their treatment. Thus patients have their treatment based on their genetic profile, molecular basis of their disease, risk of disease, or response to a particular drug therapy, rather than the signs or symptoms of their disease.
Traditionally patients have been prescribed their medication based on the signs and symptoms of their disease. If a treatment is not successful patients have to be prescribed an alternative medication.
Academic and clinical research has revealed that most diseases have multiple subtypes that require different treatment approaches. Pharmacogenetic data and bespoke diagnostic tests enable clinicians to identify the subcategory of disease and offer patients the most effective treatments from the outset of their treatment.